COFCO Biotechnology Management
Management criteria checks 1/4
COFCO Biotechnology's CEO is De Guo Zhang, appointed in Mar 2023, has a tenure of 1.75 years. directly owns 0.013% of the company’s shares, worth CN¥1.36M. The average tenure of the management team and the board of directors is 4.4 years and 1.2 years respectively.
Key information
De Guo Zhang
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.01% |
| Management average tenure | 4.4yrs |
| Board average tenure | 1.2yrs |
Recent management updates
Recent updates
COFCO Biotechnology Co., Ltd. (SZSE:000930) Surges 39% Yet Its Low P/S Is No Reason For Excitement
Oct 14
We Think COFCO Biotechnology (SZSE:000930) Has A Fair Chunk Of Debt
Sep 30COFCO Biotechnology Co., Ltd. (SZSE:000930) Looks Inexpensive But Perhaps Not Attractive Enough
Jul 17COFCO Biotechnology (SZSE:000930) Is Carrying A Fair Bit Of Debt
Jun 03Returns On Capital Signal Tricky Times Ahead For COFCO Biotechnology (SZSE:000930)
Apr 17COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Price Is Right But Growth Is Lacking
Mar 07CEO
De Guo Zhang (48 yo)
1.8yrs
Tenure
CN¥1,801,000
Compensation
Mr. De Guo Zhang serves as General Manager at COFCO Biotechnology Co., Ltd. since March 16, 2023 and served as its Deputy General Manager since August 09, 2019 until March 16, 2023. He is Non-Independent D...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 1.8yrs | CN¥1.80m | 0.013% CN¥ 1.4m | |
| Board Secretary | 5.3yrs | CN¥1.46m | 0.0070% CN¥ 743.0k | |
| Chief Accountant & Financial Manager | 4.4yrs | no data | no data |
4.4yrs
Average Tenure
50yo
Average Age
Experienced Management: 000930's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 11.8yrs | CN¥1.80m | 0.013% CN¥ 1.4m | |
| Chairman of the Board | less than a year | no data | no data | |
| Director | less than a year | CN¥86.90k | no data | |
| Independent Director | 3.3yrs | CN¥120.00k | no data | |
| Employee Supervisor | 5.3yrs | no data | no data | |
| Chairman of the Supervisory Board | 1.6yrs | no data | no data | |
| Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Employee Supervisor | 1.5yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.2yrs
Average Tenure
50yo
Average Age
Experienced Board: 000930's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 03:34 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
COFCO Biotechnology Co., Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jun Huang | China Merchants Securities Co. Ltd. |
| Xia Sheng | Citic Securities Co., Ltd. |
| Jian Zhou | Guoyuan Securities Co., Ltd. |